Life science organizations are using Fusion in diagnostic, nutritional, and therapeutic development. Targets (genes, transcripts, proteins) are a critical component to drug mechanism of action and are directly measured with molecular diagnostics. The ability to identity, rank, use, and protect these multiple products is essential for biological science and business because the majority of target diversity is the result of alternative splicing and other phenomena that give one gene multiple products.

In support of this, the Biotique Fusion tool will, given genomic, mRNA, and EST sequence, provide a comprehensive and annotated view of genes, transcripts (including alternative splice variants), and proteins. Fusion results classify known forms of targets and discover high-quality, novel isoforms previously unknown but “hidden” in the complexity of public and proprietary databases.

Fusion can either be used as a data set built from public data or can be used as a tool run locally. When run locally, Fusion can process public genomic, EST, mRNA, and gene data to create models of genes and multiple gene products (transcripts and proteins).